Sirolimus Increases T-Cell Abundance in the Sun Exposed Skin of Kidney Transplant Recipients

BACKGROUND: Kidney transplant recipients (KTRs) receiving the mammalian target of rapamycin inhibitor sirolimus may display a reduced risk of skin cancer development compared to KTRs receiving calcineurin inhibitors. Despite studies investigating the effects of these 2 drug classes on T cells in pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Michael Thomas, Sambira Nahum, Lauren C., Isbel, Nicole M., Carroll, Robert P., Soyer, Hans Peter, Francis, Ross, Bridge, Jennifer Anne, Hawley, Carmel, Oliver, Kimberly, Staatz, Christine E., Wells, James William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498012/
https://www.ncbi.nlm.nih.gov/pubmed/28706974
http://dx.doi.org/10.1097/TXD.0000000000000694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498012/
https://www.ncbi.nlm.nih.gov/pubmed/28706974
http://dx.doi.org/10.1097/TXD.0000000000000694

Ejemplares similares